Constellation of Neurological Signs in Patients with Diabetes Mellitus of more than 5 Year

Authors

  • Zakia Kanwal Author
  • Abdul Khalid Awan Author
  • Syeda Aiman Naqvi Author
  • Shaista Imtiaz Author
  • Zainab Shahab Author
  • Tayyaba Haroon Author

DOI:

https://doi.org/10.51985/JBUMDC2025780

Keywords:

Diabetes Mellitus, Diabetic Neuropathies, Glycated Hemoglobin

Abstract

 Objective: To identify the prevalence and related characteristics of peripheral neuropathy among diabetes mellitus patients
with over five years of duration.
Study Design and Setting: A cross-sectional study at the Abbas Institute of Medical Sciences in Muzaffarabad, Azad
Jammu and Kashmir.
Methodology: Non-probability consecutive sampling was used to select 266 patients with a diagnosis of either type 1 or
type 2 diabetes mellitus of a duration of greater than five years. Patients with a history of vitamin B12 deficiency,
cerebrovascular accident, or motor neuron disease were excluded. Sociodemographic data, clinical history, smoking, family
history of diabetes, and comorbidities data were obtained. The data analysis was conducted using SPSS version 22. Poststratification Chi-square test was used, and p= 0.05 was regarded as significant.
Results: The mean age of participants was 52.6 ± 10.8 years, with a mean diabetes duration of 9.4 ± 3.2 years and a mean
HbA1c of 8.6 ± 1.4%. Peripheral neuropathy was detected in 53.4% of patients. Significant associations were observed
with age =50 years (p = 0.012), rural residence (p = 0.042), illiteracy (p = 0.021), smoking (p = 0.011), hypertension (p =
0.034), diabetes duration =10 years (p < 0.001), and HbA1c =8% (p < 0.001). Gender and family history were not significantly
associated.
Conclusion: Long-term diabetes patients are very susceptible to peripheral neuropathy. Its burden should be mitigated by
implementing early screening and managing all risk factors, particularly those that are modifiable, i.e., glycaemic control,
hypertension, and smoking. 

References

1. Rahman MS, Hossain KS, Das S, Kundu S, Adegoke EO,

Rahman MA, Hannan MA, Uddin MJ, Pang MG. Role of

Insulin in Health and Disease: An Update. Int J Mol Sci. 2021

Jun 15;22(12):6403. doi: 10.3390/ijms22126403.

2. Yameny, A. Diabetes Mellitus Overview 2024. Journal of

Bioscience and Applied Research, 2024; 10(3): 641-645. doi:

10.21608/jbaar.2024.382794

3. Ali MM, Khalid H, Haneef M, Iqbal S, Ashraf A. The Growing

Burden of Diabetes Mellitus in Pakistan: Epidemiology, Risk

Factors, Challenges, and Public Health Interventions. Journal

of Health, Wellness and Community Research. 2025:e362-

e. DOI: https://doi.org/10.61919/txvzs558

4. Hajam YA, Rani R, Malik JA, Pandita A, Sharma R, Kumar

R. Diabetes Mellitus: signs and symptoms, epidemiology,

current Prevention, Management Therapies, and treatments.

Antidiabetic Potential of Plants in the Era of Omics: Apple

Academic Press; 2022. p. 31-77.

5. Pop-Busui R, Ang L, Boulton AJM, Feldman EL, Marcus

RL, Mizokami-Stout K, Singleton JR, Ziegler D. Diagnosis

and Treatment of Painful Diabetic Peripheral Neuropathy.

Arlington (VA): American Diabetes Association; 2022 Feb.

PMID: 35544662. DOI: 10.2337/db2022-01

6. Mukherjee S, Ali S, Hashmi S, Jahan S. History, origin and

types of neurological disorders. Applications of stem cells

and derived exosomes in neurodegenerative disorders:

Springer; 2023. p. 1-32.https://doi.org/10.1007/978-981-99-

3848-3_1

7. González P, Lozano P, Ros G, Solano F. Hyperglycemia and

Oxidative Stress: An Integral, Updated and Critical Overview

of Their Metabolic Interconnections. Int J Mol Sci. 2023 May

27;24(11):9352. doi: 10.3390/ijms24119352.

8. Pardina E, Tondo M, Escolà-Gil JC, Rossell J, Julve J.

Molecular mechanisms involved in hyperglycemia-induced

cellular damage. Chronic Complications of Diabetes Mellitus.

2024:25-38. https://doi.org/10.1016/B978-0-323-88426-

6.00012-9

9. Tavakoli M, Klingelhöfer D, Fadavi H, Groneberg DA. The

landscape of global research on diabetic neuropathy. Front

Endocrinol (Lausanne). 2023 Nov 7;14:1220896. doi:

10.3389/fendo.2023.1220896.

10. Borrelli EP. Estimating the annual cost burden of diabetic

peripheral neuropathy in the United States. Endocrine. 2025

Jun 14. doi: 10.1007/s12020-025-04318-4.

11. Jensen TS, Karlsson P, Gylfadottir SS, Andersen ST, Bennett

DL, Tankisi H, et al. Painful and non-painful diabetic

neuropathy, diagnostic challenges and implications for future

management. Brain. 2021;144(6):1632-45.

12. Akhtar S, Hassan F, Saqlain SR, Ali A, Hussain S. The

prevalence of peripheral neuropathy among the patients with

diabetes in Pakistan: a systematic review and meta-analysis.

Scientific Reports. 2023;13(1):11744.

13. Lu Y, Xing P, Cai X, Luo D, Li R, Lloyd C, et al. Prevalence

and risk factors for diabetic peripheral neuropathy in type 2

diabetic patients from 14 countries: estimates of the

INTERPRET-DD study. Frontiers in public health. 2020;8:

534372.

14. Braffett BH, Gubitosi-Klug RA, Albers JW, Feldman EL,

Martin CL, White NH, et al. Risk factors for diabetic peripheral

neuropathy and cardiovascular autonomic neuropathy in the

Diabetes Control and Complications Trial/Epidemiology of

Diabetes Interventions and Complications (DCCT/EDIC)

study. Diabetes. 2020;69(5):1000-10.

15. Nozawa K, Ikeda M, Kikuchi S. Association Between HbA1c

Levels and Diabetic Peripheral Neuropathy: A Case–Control

Study of Patients with Type 2 Diabetes Using Claims Data.

Drugs-real world outcomes. 2022;9(3):403-14.

16. Chang K-C, Pai Y-W, Lin C-H, Lee I-T, Chang M-H. Glycemic

variability’s impact on painful diabetic peripheral neuropathy

in type 2 diabetes patients. Scientific Reports.

2024;14(1):22276.

17. Clair C, Cohen MJ, Eichler F, Selby KJ, Rigotti NA. The

effect of cigarette smoking on diabetic peripheral neuropathy:

a systematic review and meta-analysis. Journal of general

internal medicine. 2015;30(8):1193-203.

18. Walicka M, Krysiñski A, La Rosa GRM, Sun A, Campagna

D, Di Ciaula A, et al. Influence of quitting smoking on

diabetes-related complications: A scoping review with a

systematic search strategy. Diabetes & Metabolic Syndrome:

Clinical Research & Reviews. 2024;18(5):103044.

19. Sethi Y, Uniyal N, Vora V, Agarwal P, Murli H, Joshi A, et

al. Hypertension the ‘missed modifiable risk factor’for diabetic

neuropathy: a systematic review. Current problems in

cardiology. 2023;48(4):101581.

20. Kamalarathnam SR, Varadarajan S. Diabetic peripheral

neuropathy in diabetic patients attending an urban health and

training centre. Journal of family medicine and primary care.

2022;11(1):113-7.

21. Mekuria Negussie Y, Tilahun Bekele N. Diabetic peripheral

neuropathy among adult type 2 diabetes patients in Adama,

Ethiopia: health facility-based study. Scientific reports.

2024;14(1):3844.

Downloads

Published

2026-01-14

Issue

Section

Original Articles

Similar Articles

You may also start an advanced similarity search for this article.